Falko Friedrichs is ranked #1491 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Falko Friedrichs (Deutsche Bank ) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Falko Friedrichs's stock ratings?

About 67% of Falko's ratings were profitable over a one-year hold, with an average return of -18.1% per rating, measured by 13Foresight from historical prices.

Analyst Tracker/Falko Friedrichs

Falko Friedrichs

Deutsche Bank

Wall Street Analyst

★★★☆☆

#1491

on 13Foresight · ranked by our own returns

67%

Success Rate

-18.1%

Average Return

2 of 3 calls profitable · +4.9% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

🔒 3-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 67% of Falko Friedrichs's ratings turned a profit when each position was held for 1 year — averaging -18.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

42 Buy 63 Hold 0 Sell

Falko's Stock Coverage 33 ratings · 2026-07-12

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
IT:1SXP SCHOTT Pharma AG & Co. KGaA	Jul 09, 2026	BUY	Buy +6.6% avg upside 6 analysts	$23.00 14.96% Upside	·
WILLF Demant	Jul 06, 2026	HOLD	Strong Buy -3.5% avg upside 19 analysts	$39.40 5.19% Downside	·
DE:SHL Siemens Healthineers AG	Jul 06, 2026	HOLD	Buy +45.1% avg upside 23 analysts	$38.00 9.88% Upside	·
DE:GXI Gerresheimer	Jun 30, 2026	HOLD	Buy +111.9% avg upside 15 analysts	$22.00 22.75% Downside	·
FR:EL EssilorLuxottica SA	Jun 24, 2026	HOLD	Strong Buy +11.4% avg upside 17 analysts	$181.00 5.53% Upside	·
SE:EKTA.B Elekta AB	Jun 22, 2026	HOLD	Strong Sell +17.1% avg upside 12 analysts	$52.00 1.14% Upside	·
DE:SRT3 Sartorius	Jun 22, 2026	BUY	Buy +14.2% avg upside 18 analysts	$284.00 17.41% Upside	·
DE:FRE Fresenius SE & Co. KGaA	Jun 16, 2026	BUY	Strong Buy +19.9% avg upside 20 analysts	$55.00 29.13% Upside	·
DE:MRK Merck KGaA	May 27, 2026	HOLD	Buy -2.8% avg upside 33 analysts	$125.00 10.45% Downside	·
CH:LONN Lonza Group Ltd	May 18, 2026	BUY	Strong Buy +9.8% avg upside 20 analysts	$656.00 11.93% Upside	·
DE:AFX Carl Zeiss Meditec	May 13, 2026	HOLD	Hold +55.0% avg upside 13 analysts	$30.00 1.95% Downside	·
CH:ALC Alcon	May 12, 2026	BUY	Buy +30.5% avg upside 35 analysts	$70.00 28.59% Upside	·
DE:OBCK Ottobock SE & Co. KGaA	May 12, 2026	BUY	Strong Buy +67.3% avg upside 4 analysts	$83.00 65.58% Upside	·
DE:FME Fresenius Medical Care AG & Co. KGaA	May 06, 2026	HOLD	Hold +21.6% avg upside 22 analysts	$40.00 4.68% Downside	·
NL:PHIA Koninklijke Philips N.V.	Apr 01, 2026	HOLD	Buy +28.5% avg upside 21 analysts	$25.00 3.97% Upside	·
CH:SOON Sonova Holding AG	Mar 25, 2026	HOLD	Sell +9.8% avg upside 17 analysts	$188.00 7.34% Downside	·
DE:BAYN Bayer	Mar 05, 2026	HOLD	Strong Buy +3.9% avg upside 28 analysts	$23.00 54.03% Downside	·
CH:STMN Straumann Holding AG	Oct 01, 2025	HOLD	Buy +17.4% avg upside 15 analysts	$99.00 5.85% Downside	·
GB:0QBO Coloplast A/S	Sep 08, 2025	HOLD	Buy +80.9% avg upside 17 analysts	$660.00 63.23% Upside	·
QGEN Qiagen	Apr 07, 2025	BUY	Buy +1.8% avg upside 24 analysts	$49.47 19.11% Upside	+0.1%
DE:EVT Evotec	Nov 25, 2024	SELL	Buy +235.3% avg upside 8 analysts	$4.00 19.10% Downside	·
EVO Evotec AG	Apr 12, 2024	BUY	Strong Buy +256.6% avg upside 9 analysts	$19.00 582.14% Upside	-56.4%
FR:EAPI Euroapi SA	Jan 25, 2024	HOLD	Buy +535.3% avg upside 5 analysts	$6.00 377.61% Upside	·
DE:SRT Sartorius	Oct 04, 2023	BUY	Strong Buy +91.7% avg upside 5 analysts	$414.00 111.60% Upside	·
DE:SBS STRATEC Biomedical	Mar 13, 2023	HOLD	Strong Buy +213.7% avg upside 5 analysts	$71.00 273.61% Upside	·
BBLNF Babylon Holdings	Aug 23, 2022	BUY	Buy +65549900.0% avg upside 6 analysts	$125.00 124999900.02% Upside	·
DE:BNN B.R.A.I.N. Biotechnology Research and Information Network	Oct 20, 2021	BUY	Strong Buy +207.3% avg upside 3 analysts	$13.00 360.93% Upside	·
FMS Fresenius Medical Care	Feb 03, 2021	HOLD	Hold +77.9% avg upside 14 analysts	—	+2.1%
DE:FNTN freenet	Feb 02, 2021	HOLD	Buy +12.1% avg upside 18 analysts	$21.00 11.83% Downside	·
CH:UBSG UBS Group AG	Apr 29, 2020	HOLD	Buy -19.0% avg upside 23 analysts	$9.00 78.64% Downside	·
GB:AZN AstraZeneca	Sep 09, 2019	BUY	Strong Buy +16.5% avg upside 26 analysts	$7800.00 39.21% Downside	·
DE:DRW3 Draegerwerk AG & Co. KGaA	Aug 14, 2019	HOLD	Buy -6.9% avg upside 2 analysts	$46.00 45.17% Downside	·
DE:DRW8 Draegerwerk AG & Co. KGaA	Aug 14, 2019	HOLD	Hold -29.6% avg upside 3 analysts	$46.00 33.99% Downside	·

🔒 28 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Falko Friedrichs — Frequently Asked Questions

How accurate are Falko Friedrichs's stock ratings?

Based on the calls 13Foresight could measure, about 67% of Falko's ratings were profitable over a one-year hold, with an average return of -18.1% per rating, or -36.9% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Falko ranked on 13Foresight?

Falko Friedrichs is currently ranked #1491 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Falko cover?

Falko most recently has ratings on IT:1SXP, WILLF, DE:SHL, DE:GXI, FR:EL, SE:EKTA.B, DE:SRT3, DE:FRE, DE:MRK, CH:LONN, DE:AFX, CH:ALC and 21 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!